✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (248 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
35.61
3,88,680
68.10
1,68,817
61.31
1,39,297
19.72
1,09,828
22.60
1,04,973
23.00
1,04,588
52.59
93,582
18.89
93,293
23.55
82,114
60.89
64,851
26.37
62,518
71.28
60,113
93.80
56,675
35.13
53,545
41.03
41,895
92.05
41,539
43.45
39,531
34.08
34,572
42.69
32,175
35.75
31,096
33.25
28,165
1,037
22,831
66.16
22,027
-
21,992
25.38
21,659
105
21,254
1,034
20,797
68.33
19,609
12.57
19,567
44.16
19,067
103
18,487
31.30
17,076
34.77
15,043
23.47
14,764
41.24
14,338
21.26
13,050
93.92
12,619
22.29
12,119
26.95
11,829
56.47
11,389
52.40
10,847
34.01
10,627
44.05
10,576
66.80
9,983
19.25
9,845
117
9,026
23.93
8,621
29.07
8,533
25.44
8,096
53.94
8,093
24.19
7,901
55.43
7,688
23.84
6,998
29.40
6,284
27.53
5,966
-
5,325
28.07
5,201
-
4,522
-
4,475
31.34
4,149
82.14
3,925
41.45
3,714
33.44
3,397
16.64
3,372
21.99
3,348
16.52
3,346
59.54
2,979
152
2,870
25.46
2,778
22.28
2,647
8.89
2,623
22.54
2,612
7.39
2,355
-
2,308
22.99
2,286
-
2,254
-
2,239
151
2,147
-
1,909
27.25
1,819
29.85
1,687
29.24
1,664
48.99
1,428
55.50
1,400
39.32
1,380
32.74
1,339
21.65
1,300
31.12
1,274
16.62
1,268
18.35
1,265
13.76
1,209
4.79
1,192
35.64
1,165
20.88
1,092
25.18
1,068
31.63
1,046
44.88
1,040
10.70
939
21.12
908
-
891
44.08
884
41.06
842
-
833
19.38
811
45.39
751
45.69
729
35.25
637
44.10
589
27.34
542
20.23
527
48.76
512
39.27
475
14.22
461
64.06
447
41.55
399
19.72
391
43.70
351
36.90
348
29.36
341
68.19
335
33.29
322
25.65
301
-
298
33.61
289
-
287
29.70
285
84.00
278
24.44
270
46.28
270
24.26
258
14.30
252
25.45
250
72.81
250
30.39
249
79.79
247
-
229
20.69
216
-
213
24.89
206
30.81
205
-
205
9.22
199
42.27
191
14.77
185
13.31
181
36.63
176
18.20
175
32.22
172
660
171
-
165
6.73
163
12.95
159
52.71
156
58.47
153
10.91
153
12.50
146
29.46
142
557
140
29.31
134
16.11
129
-
128
18.67
125
14.94
121
31.63
117
13.51
116
197
112
12.26
107
-
105
-
105
14.74
100
26.25
98
15.52
95
72.52
88
18.14
86
30.01
84
-
81
109
80
-
76
4.19
74
10.36
74
15.94
69
6.47
69
-
65
13.55
61
13.82
59
11.80
58
13.27
56
-
56
7.49
54
19.38
54
21.39
53
-
52
130
52
-
49
14.40
48
210
47
-
44
57.37
44
18.38
43
22.47
43
27.26
42
94.92
42
-
40
50.83
40
-
38
34.87
37
-
36
-
34
6.53
32
34.91
30
350
30
-
29
-
28
12.13
28
6.51
27
6.32
26
29.03
25
7.14
24
27.18
24
10.69
22
-
21
10.12
21
37.44
17
-
16
51.21
15
-
15
40.87
14
94.68
13
21.13
13
12.96
13
-
12
24.01
12
-
12
-
12
846
11
67.60
10
9.04
9
-
8
-
7
89.76
7
824
7
-
7
-
5
-
5
66.51
4
39.38
4
-
3
-
2
Showing 5 248 of 248 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material